
BioDAR’s Managing Director, Dr Sherif Abouelhadid, participated in the Innovations and Immunotherapy for Infectious Diseases (I4ID) Congress in Lyon, 2025. During the congress, Dr Abouelhadid chaired two sessions highlighting recent advances in combating antimicrobial resistance and exploring novel alternatives to traditional antimicrobials.




